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Mouse hepatitis virus (MHV) A59 temperature-sensitive (ts) mutants belonging to complementation group
C were characterized and mapped by standard genetic recombination techniques. Temperature shift
experiments early in infection suggested that the group C allele can be divided into two phenotypically distinct
subgroups, designated Cl and C2. Since previous data indicated that the group Cl mutants probably contained
an early defect which affects negative-strand synthesis, RNA synthesis was further examined by analyzing
replicative-form (RF) RNA. Full-length as well as subgenomic-length RF RNAs were radiolabeled from 3 to 12
h postinfection (p.i.) and labeled late in infection after shift to the nonpermissive temperature (39.5°C). The
relative percent molar ratios of each mRNA and corresponding RF RNA were roughly equivalent throughout
infection. Temperature shift experiments at 5.5 or 6.0 h p.i. resulted in an 83 to 92% reduction in the amount
of total RF RNA at 39.5°C. Radiolabeling time course experiments after temperature shift to 39.5°C also
demonstrated incorporation (6 to 9 h p.i.) into both subgenomic-length and full-length RF RNAs, suggesting
that previously transcribed negative strands were functional templates throughout infection. To determine if
the reduction in RF RNA was due to a decrease in positive- or negative-strand RNA synthesis, rates of mRNA
synthesis were calculated from both full-length and subgenomic-length templates. The rate of mRNA synthesis
after the shift was increased at 39.5°C compared with that at 32°C regardless of the template used; however,
transcription rates calculated from subgenomic-length templates were similar to those of other viral and
eukaryotic polymerases. These findings support the notion that the group Cl allele regulates negative-strand
RNA synthesis and strongly suggest that the subgenomic negative-strand RNAs are probably the predominant
functional templates for the synthesis of positive-strand RNAs late in infection.
The genome of mouse hepatitis virus (MHV), a coronavirus,
consists of an approximately 31-kb single-stranded plus-polar-
ity RNA (19, 23, 29). Replication of genomic RNA occurs
through a negative-strand RNA intermediate and results in the
synthesis of six or seven subgenomic mRNAs as well as
additional progeny genomic RNA (34, 38, 40). The mRNAs
are arranged in a 3'-coterminal nested set and contain a 5'-end
leader RNA sequence of approximately 70 nucleotides that is
derived from the 5' end of the genome and is fused to mRNA
at highly conserved intergenic sequences [UC(U/C)AAAC] (4,
6, 8, 15, 40). During mixed infection, leader RNA sequences
from one strain ofMHV are joined to the subgenomic mRNAs
of heterologous MHV strains (28, 44). Heterogeneity can also
occur at the leader-body fusion sites, as well as in less-than-
perfect intergenic sequences that can function as transcrip-
tional start sites for mRNA synthesis (17, 25, 27, 34, 38, 42).
Both full-length and subgenomic-length negative-strand RNAs
and replicative-form (RF) RNAs have been detected in coro-
navirus-infected cells including porcine transmissible gastroen-
teritis virus, bovine coronavirus, and MHV (11, 33, 34, 37).
Several discontinuous-transcription models have been pro-
posed to explain the presence of leader RNAs on positive-
strand RNAs and antileader RNAs on full-length and sub-
genomic-length negative-strand RNAs (15, 33, 36, 40). It has
been suggested that transcription may occur in two phases: an
early, primary phase in which subgenomic-length mRNA is
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first synthesized from a full-length template, and a secondary
phase in which it is synthesized from a subgenomic-length
template (13, 23, 33, 37, 43). One model proposes that
subgenomic mRNA is initially synthesized from a full-length
negative-strand template by a leader-priming mechanism fol-
lowed by mRNA amplification through a subgenomic negative-
strand intermediate (4, 37). This model is consistent with
results of leader reassortant studies and also of UV transcrip-
tional mapping studies, which suggest that early in MHV
infection the production of genome-length and subgenomic-
length mRNA is inhibited at equivalent UV doses (28, 43).
While it is clear from nascent-labeling experiments that sub-
genomic-length replicative-intermediate (RIs) are transcrip-
tionally active (33), it has been suggested that these sub-
genomic RIs may represent dead-end transcriptional products
involved in the synthesis of a single mRNA (13).
Alternative models propose that subgenomic-length nega-
tive strands are synthesized directly from the genomic tem-
plate, either by a looping out or splicing mechanism or by
transcription attenuation within intergenic regions, to provide
the template for subsequent mRNA synthesis (33). Currently,
the looping-out mechanism is less attractive since it has not
been demonstrated that full-length RIs can be degraded into
subgenomic RF RNA (3, 33).
In this study, ts mutants defective in negative-strand synthe-
sis were used to study the synthesis and function of the
full-length versus subgenomic-length RNA in MHV-infected
cells. Our data provide strong genetic support for the hypoth-
esis that subgenomic negative-stranded RNAs are the predom-
inant functional templates for the synthesis of subgenomic
mRNAs late in infection (33, 36, 37).
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MATERIALS AND METHODS
Virus, cell lines, and recombination mapping. MHV A59 ts
mutants (NC1, NC3, NC10, and LA9) belonging to RNA-
complementation group C were used in this study (35).
Complementation indices among the group C mutants were
determined as previously described (35). Revertants of LA9
and NC3 were obtained by isolating plaques that initially grew
at 39.5°C and which maintained the ability to grow at restric-
tive temperatures after successive plaque assays, as previously
described (9). Mutants and revertants were propagated in
DBT cells, a murine astrocytoma cell line, in Dulbecco's
modified minimum essential medium (DMEM) containing
10% Nu-serum (Irvine Scientific) and 1% gentamicin-kana-
mycin (35). The 17CL1 cells (kindly provided by Stanley
Sawicki) were maintained in DMEM containing 6% fetal calf
serum, 5% tryptose phosphate broth, and 1% penicillin-
streptomycin. To reduce fusion of the 17CL1 cells during
infection, medium at pH 6.8 was used as previously described
(32).
Recombination analyses, measuring the percentage of ts+
progeny virus present following a genetic cross at the permis-
sive temperature, were performed as previously described (2).
Recombination frequencies are presented as mean ± standard
deviation from at least three independent assays.
Virus growth curves. Growth curves for NC1, NC3, NC10,
LA9, and LA9-Rev2 (revertant no. 2) were determined as
previously described (35). Briefly, cultures were infected at a
multiplicity of infection (MOI) of 10 at the permissive temper-
ature (32°C) and maintained at this temperature until 5 h
postinfection (p.i.), when half the cultures were shifted up to
39.5°C. Virus progeny were harvested at 2, 5, 7, 9, 11, and 14 h
p.i. for analysis by plaque assay. At the indicated times p.i.,
intracellular RNA was harvested and equivalent amounts were
bound to nitrocellulose filters, probed with strand-specific
RNA probes, and quantified as previously described (35).
Radiolabeling and isolation of viral RNA. Viral RNAs were
radiolabeled in DBT or 17CL1 cells. After infection, cultures
were overlaid with complete DMEM for DBT cells or pH 6.8
DMEM for 17CL1 cells and incubated at 32°C. At least 30 min
prior to the addition of radioisotope, the cultures were treated
with actinomycin D (Sigma) at concentrations ranging from 2.5
to 10 ,ug/ml. Higher concentrations of actinomycin D were
used in 32Pi-labeling experiments to reduce radiolabeling of
host cell RNA and DNA. [3H]uridine (Amersham) at 100
,uCi/ml (for mRNA labeling only) or 300 ,uCi/ml (for analysis
of RF RNAs) was added to virus-infected cultures at different
times p.i. for 2 h as indicated in the figure legends. For labeling
with 3 (ICN), cultures of 17CL1 cells were grown overnight
in 90% phosphate-free MEM (Gibco) containing 10% fetal
calf serum and then 300 ,uCi of radiolabel per ml was added to
the cultures at different times p.i. in 100% phosphate-free
MEM. All viral RNA was extracted as described elsewhere
(33).
Analysis of viral RNA. Viral mRNA and RF RNA were
analyzed by the method described by Sawicki and Sawicki (33).
Briefly, RNA was treated with 10 U of DNase I (Boehringer
Mannheim) in lx DNase buffer (500 mM NaCl, 50 mM Tris
[pH 7.8], 10 mM CaCl2, 10 mM MgCl2) for 15 min at 30°C.
One-sixth of the total RNA was set aside to be heat denatured
at 90°C and analyzed as mRNA, while the remaining five-sixths
of the sample was analyzed as RF RNA and digested with 50
ng of RNase A (Sigma) per ml in 1 x RNase buffer (700 mM
NaCl, 10 mM Tris [pH 7.4], 30 mM EDTA) for an additional
15 min at 30°C. The RNA was electrophoresed on lx Tris-
borate-EDTA (TBE)-0.8% agarose gels, soaked in Enlighten-
ing (Dupont NEN) if 3H labeled, and dried under vacuum
before exposure to Hyperfilm-MP (Amersham) at -70°C.
Dried gels containing 32Pi-labeled viral RNAs were scanned
for 10 to 12 h by the AMBIS radioanalytic imaging system
(Ambis, San Diego, Calif.). The relative percent molar ratios
of mRNA and RF RNA were calculated as previously de-
scribed (18, 19).
Calculation of rates of mRNA synthesis. Total counts per
minute (cpm) obtained by the AMBIS radioanalytic imaging
system were corrected for background signal, resulting in net
cpm. The net cpm value was then corrected for sample volume
loaded onto gels; i.e., mRNA counts were multiplied by 6, and
RF counts were multiplied by 6/5. To determine whether rates
of mRNA synthesis were affected by the ts lesion in NC3, rates
of transcription were calculated by assuming that either a
full-length or a same-sized negative-strand template func-
tioned exclusively in mRNA synthesis. This was necessary since
the actual template for mRNA synthesis late in infection is
controversial (1, 13, 33, 37, 44). Calculations to determine the
time required to transcribe an MHV mRNA from a same-sized
subgenomic-length RF template were based on the general
formula used for Sindbis (SB) virus (3, 39). This was probably
a valid assumption since the rates of SB virus 42S or 26S RNA
synthesis were also calculated from distinct same-sized RF
RNA templates, i.e., RFI or RFIII, respectively (3, 39).
Assuming that positive-strand RNA is preferentially labeled
from the subgenomic-length template (33), the formula to
calculate the time of synthesis of one mRNA from one
subgenomic-length RF template (TA) is: TA = T/(AIB), where
T is the labeling time (60 min), A is a particular mRNA cpm,
and B is the cpm from its corresponding-length RF RNA (3,
39).
The above formula is valid only if subgenomic negative
strands are not transcriptionally dead-end products involved in
the synthesis of a single positive strand (13). If this is the case,
the "leader-primed" transcription model dictates that all viral
mRNAs will be transcribed from a full-length RI, predicting
that only that portion of the full-length RI that is equivalent to
the size of a given mRNA functions in the synthesis of that
mRNA. The nested-set structure of the MHV mRNAs further
dictates that nascent positive strands destined to become each
viral mRNA will also be present on the full-length RI (4).
Thus, to calculate the rate of mRNA synthesis, assuming that
only leader-primed transcription from full-length RI templates
was functioning, we modified and substituted B in the above
formula to correct for (i) the portion of the full-length RF
RNA that could be contributing to the synthesis of a particular
subgenomic mRNA, (C(D/E) (see below), and (ii) the ratio of
nascent positive strands synthesized from this portion of the
RF RNA (A/F). As predicted from the leader-primed tran-
scription model (4), we have assumed that the ratio of nascent
positive strands on the full-length RIs (A/F) should reflect the
final ratio of a given mRNA (A) to all mRNA transcribed
during the labeling period (F). Since mRNAs do not arise
spontaneously but, rather, originate as nascent positive strands
on RI RNAs, it is a valid assumption that the ratio of nascent
positive-strand RNAs on the RI RNA will reflect the final ratio
of each mRNA during transcription (4, 30, 39). Thus, B in the
original formula is substituted with (C)(D/E)(A/F), and the
final formula can be mathematically expressed as: TA = (1)
(C)(D/E)(A/F)/A, where T is the labeling time (60 min), C is
the RF1 cpm, D is the portion of the full-length template
contributing to the synthesis of a selected mRNA and is
equivalent to the size of the particular mRNA (in kilobases), E
is the size of a full-length negative-strand RNA (31 kb), A is
the selected mRNA cpm, and F is the total cpm of all mRNAs.
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TABLE 1. Virus titers of the group C mutants and revertants
Virus titer at: Reversion
Mutant reqency32°C 39.5°C frequency
NC3 3.8 x 107 1.0 X 103 2.6 x 10-5
NC10 9.3 x 107 1.0 X 102 1.2 x 10-6
NC1 7.4 x 107 1.0 X 102 1.4 x 10-6
LA9 8.6 x 107 7.8 x 103 9.0 x 10-5
LA9Revl 2.9 x 107 1.0 X 107 3.4 x 10-1
LA9Rev2 4.0 x 107 1.4 x 107 3.5 x 10-1
NC3Revl 1.0 X 108 7.0 x 107 7.0 x 10-1
NC3Rev2 1.0 x 108 7.0 x 107 7.0 x 10-1
To calculate putative polymerase rates during infection, we
converted the time (in minutes) required to transcribe mRNAs
7, 6, 3, and 1 to nucleotides per minute by dividing the time to
transcribe a given mRNA into the size (in nucleotides) of the
respective mRNA. Comparisons among calculations assume
that there are roughly equivalent amounts of RNA polymerase
and template RNAs and roughly equivalent mRNA decay
rates at different times p.i. Statistics, including mean ± stan-
dard deviation and T test, were calculated by the Statworks
(version 1.2) program (Cricket Software, Inc., Philadelphia,
Pa.).
RESULTS
Genetic mapping and phenotypic characterization of the
complementation group C mutants. We have previously shown
that at least one group C mutant (LA9) continues to synthesize
mRNA and release infectious virus after temperature shift to
39.5°C. Using strand-specific RNA probes, negative-strand
RNA synthesis did not increase significantly after the shift,
suggesting that the group C allele probably encodes an early
function affecting negative-strand synthesis (35). Table 1 shows
the titers and the reversion frequencies of the group C mutants
used in these studies. In support of previous complementation
data and RNA recombination mapping data (2, 9, 35), comple-
mentation data and detailed recombination mapping studies
among the group C mutants demonstrated that the ts alleles
were closely linked (Table 2).
Prior studies with alphaviruses have demonstrated that more
than one phenotypically distinct function may be represented
within a single complementation group (30). To determine if
phenotypically distinct subgroups exist within the group C
mutants, cultures of cells were infected with different mutants
and shifted to the restrictive temperature at 5 h p.i. Samples
were taken at different times p.i. for infectious-virus analysis by
plaque assay (Fig. 1). In contrast to LA9 and NC3, which
continue to release infectious virus after the shift, the replica-
tion of NC10 and NC1 was significantly inhibited in the ability
to produce infectious virus. To determine if the block in NC1
and NC10 was linked to the inability to transcribe mRNA,
intracellular RNA was isolated at different times after the shift,
bound to nitrocellulose filters, and probed with strand-specific
RNA probes that detect all viral mRNAs (Fig. 2) (35). While
preliminary, these results suggest that the group C ts mutants
can be subdivided into two phenotypically distinct subgroups.
The subgroup Cl mutants, represented by NC3 and LA9,
continue to release infectious virus and synthesize significant
quantities of mRNA at 39.5°C after the temperature shift at 5
h p.i. The slight delay in PFU production at 39.5°C was
probably due to a slight delay in the accumulation of viral
mRNA. In contrast, the subgroup C2 mutants, NC1 and NC10,
do not release infectious virus and synthesize little if any
mRNA at 39.5°C after the temperature shift at 5 h p.i. (Fig. 1
and 2). The LA9 and NC3 revertants transcribe mRNA and
produce infectious virus at the restrictive temperature (data
not shown), typical of all the MHV A59 revertants isolated to
date (9). We focused our efforts on the group Cl mutants since
previous studies suggested that they contain a defect in nega-
tive-strand RNA synthesis at the restrictive temperature (35).
Effect of early and late temperature shift on NC3 mRNA and
RF RNA synthesis. If subgenomic negative-strand RNAs are
functional templates for mRNA synthesis, subgenomic RF
RNAs should be detected throughout infection. We performed
a time course experiment of NC3 mRNA and RF RNA
synthesis at 32°C and after radiolabeling with [3H]uridine at
2-h intervals between 6 to 8, 8 to 10, and 10 to 12 h p.i. (Fig. 3).
To verify that the ts lesion was present in an allele which
functions early in infection, we also shifted virus-infected cells
to the nonpermissive temperature late (9 h p.i.) in infection, 1
h prior to adding label. Genome-length as well as all sub-
genomic-length mRNAs and RF RNAs were detectable
throughout the time course of the experiment (6 to 12 h p.i.).
Moreover, a temperature shift late in infection had no effect on
positive-strand synthesis, as NC3 mRNA and RF RNA synthe-
sis was essentially the same at both 32 and 39.5°C from 10 to 12
h p.i. (Fig. 3). As previously described, an eighth mRNA and
its corresponding RF RNA, which are encoded at the 3' end of
the viral genome, were also detected on occasion (34).
If the group Cl mutants were defective in the ability to
synthesize negative-strand RNA after the shift, a correspond-
ing reduction in RF RNA should be seen in cultures shifted
earlier in infection. 17CL1 cells were infected with NC3 and
shifted to the restrictive temperature at 6 h p.i. The viral RNA
was radiolabeled with 32Pi from 6.5 to 9 h p.i. Following the
temperature shift, NC3 full-length as well as subgenomic-
length mRNA and RF RNA were prevented from increasing to
maximal levels as detected at the permissive temperature (Fig.
4). AMBIS radioanalytic imaging system scans indicated that
after the shift to 39.5°C, NC3 total RF RNA and mRNA levels
were reduced by approximately 92 and 49%, respectively,
relative to those of controls maintained at 32°C.
Time course of RF RNA synthesis after the temperature
shift. If subgenomic negative strands are dead-end transcrip-
tional products and the group Cl mutants transcribe little new
TABLE 2. Genetic recombination frequencies and complementation indices among the group C mutants
Recombination frequency' (complementation index) for:
Mutant
LA9 NC10 NC3 NC1 LA7
LA9 0.20 ± 0.05 (0.1) 0.10 ± 0.09 (0.8) 0.65 ± 0.63 (3.0) 4.45 ± 0.85 (34.2)
NC10 0.79 ± 0.20 (0.8) 0.08 ± 0.005 (0.5) 4.85 ± 1.00 (45.0)
NC3 0.47 ± 0.22 (0.1) 3.74 ± 2.30 (250.0)
NC1 3.65 ± 2.30 (129.2)
LA7
I Mean ± standard deviation.
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FIG. 1. Growth curves of the group C mutants. Infection was initiated at 320C, and at 5 h p.i. half the cultures were shifted to 39.50C. Infectious
virus was analyzed by plaque assay. (A) NC1; (B) NC10; (C) NC3; (D) LA9; (E) LA9-Rev2. Symbols: *, 32°C; 0, 39.5°C.
negative-strand RNA after the temperature shift (35), a de-
crease in 32Pi incorporation into the subgenomic-length but not
full-length RFs at 39.5°C should be evident over time as the
preexisting subgenomic templates transcribe a single positive
strand and burn out. This should also result in an alteration in
the relative percent molar ratio of full-length to subgenomic-
length RF RNAs after the shift. We analyzed the kinetics of
NC3 and NC3-Rev2 RF RNA synthesis at 32 and 39.5°C from
4 to 9 h p.i. Infected cultures were shifted at 5.5 h p.i. and
radiolabeled with 32p; from 6 to 7, 7 to 8, and 8 to 9 h p.i. (Fig.
5). Consistent with previous studies, very little mRNA and RF
RNA were observed with both NC3 and NC3-Rev2 at 4 and 5
h p.i. in cultures maintained at 32°C (35). NC3-Rev2 mRNA
and RF RNA synthesis increased later in the infection and
peaked by 8 to 9 h p.i. at 32°C and by 7 h p.i. at 39.5°C (Fig. SC
and D). With NC3 at 32°C, synthesis of full-length and
subgenomic-length RF RNA rapidly increased between 7 and
9 h p.i. (Fig. SB). At 39.5°C after the temperature shift at 5.5
h p.i., a reduction in the amount of NC3 full-length and
subgenomic-length RF RNA and mRNAs was observed at
each labeling period compared with that in the controls (Fig.
5A and B).
To quantitatively determine the levels of mRNA and RF
RNA synthesized after the temperature shift, the four 32P-
labeled gels shown in Fig. 5 were scanned by the AMBIS
radioanalytic imaging system. Figure 6 is a graphic represen-
tation of the net cpm for NC3 and NC3-Rev2 mRNA and RF
RNA. As expected, the numbers reflect nearly constant levels
of total mRNA and RF RNA synthesis in NC3-Rev2 after the
temperature shift (Fig. 6B). In contrast, by 9 h p.i., NC3 total
RF RNA synthesis did not increase significantly and was
reduced by 83% compared with that in controls maintained at
the permissive temperature (Fig. 6A). While the ts defect in
NC3 also resulted in nearly equivalent reductions in the
amount of radiolabel incorporated into both RF1 and RF7
after shift (Fig. 6C), the amount of radiolabel incorporated
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FIG. 2. RNA synthesis in the group C mutants. Infection was initiated in DBT cells infected at a MOI of 10 with each ts mutant. At 5.0 h p.i.,
half of the cultures were shifted to 39.5°C and intracellular RNA was isolated as described in Materials and Methods. Equivalent amounts of RNA
were bound to nitrocellulose filters and probed with strand-specific RNA probes that detect all MHV mRNAs. The bands were visualized, excised,
and counted. (A) NC1; (B) NC10; (C) LA9. Symbols: *, 32°C; 0, 39.5°C.
increased at 39.5°C over time, clearly indicating that the
negative-strand templates were not depleted.
We also calculated the percent molar ratio of RF1 through
RF7 after the shift to the restrictive temperature and in control
cultures maintained at the permissive temperature (Table 3).
These data clearly demonstrated that the percent molar ratios
of RF1 through RF7 reflected the molar ratios of their
respective mRNAs and remained relatively constant after the
shift, indicating that the subgenomic RF RNAs are transcrip-
tionally active and are not dead-end transcription products.
Previous UV kinetic studies demonstrated that at 2.5 h p.i.
and 37°C, most of the MHV mRNAs (>80%) have a target
size larger than their respective RNA size (43). We performed
early temperature shift experiments to determine whether
primary and secondary transcription could be uncoupled.
NC3-infected cultures were shifted at 1.5 and 3.0 h p.i. and
labeled with 500 ,uCi/ml of [3H]uridine per ml from 3 to 4 or 4
to 5 h p.i., respectively. In agreement with earlier studies, viral
mRNA and RF RNA synthesis was significantly reduced when
cultures were shifted to the restrictive temperature at earlier
times p.i. (35). In cultures shifted at 1.5 h p.i., radiolabel was
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FIG. 3. Time course of [3H]uridine labeling of N3 mRNA and RF
RNA after a late shift. DBT cells were infected with NC3 at an MOI
of 6 and treated with actinomycin D 0.5 h before being labeled. Viral
mRNA and RF RNA were labeled at 100 and 300 jXCi/ml for 2-h
periods at 32°C at the times indicated below. At 9 h p.i., half the
cultures were shifted to the restrictive temperature. (A) mRNA (24-h
exposure); (B) RF RNA (60-h exposure). Lanes: 1, 6 to 8 h p.i. 32°C;
2, 8 to 10 h p.i., 32°C; 3, 10 to 12 h p.i., 32°C; 4, 10 to 12 h p.i., 39.5°C.
A B
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FIG. 4. 32Pi labeling of NC3 mRNA and RF RNA after an early
shift. 17CL1 cells were infected with NC3 at an MOI of 10 and treated
with actinomycin D at 5 h p.i. At 6 h p.i., half the cultures were shifted
to 39.50C. Viral RNA was radiolabeled from 6.5 to 9 h p.i. with 300
of 32pi per ml and extracted at 9 h p.i. (A) mRNA; (B) RF RNA.
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FIG. 5. Time course of 32P labeling of NC3 and NC3-Rev2 mRNA
and RF RNA. 17CL1 cells were infected with either mutant or
revertant at an MOI of 10 and treated with actinomycin D at least 1 h
before being labeled. The infection was initiated at the permissive
temperature, and at 5.5 h p.i. half the cultures were shifted to the
nonpermissive temperature. Viral RNA was labeled for 1-h periods at
various times postinfection with 32Pi at 300 p.Ci/ml, and the RNA was
extracted at the times indicated below. (A) NC3 mRNA; (B) NC3 RF
RNA; (C) NC3-Rev2 mRNA; (D) NC3-Rev2 RF RNA. Lanes: 1, 4 h
p.i.; 2, 5 h p.i.; 3, 7 h p.i., 32°C; 4, 7 h p.i., 39.5°C; 5, 8 h p.i., 32°C; 6,
8 h p.i., 39.5°C; 7, 9 h p.i., 32°C; 8, 9 h p.i., 39.5°C.
A B
incorporated into the smaller subgenomic mRNAs, but we
could not clearly detect significant label in any viral RF RNAs.
By 3 h p.i., label was incorporated into both full-length and
subgenomic-length mRNA and RF RNA, indicating that both
full-length and subgenomic-length negative-strand RNAs were
transcriptionally active at very early times p.i. (Fig. 7).
Time required to transcribe NC3 mRNA after the temper-
ature shift. The defect in NC3 transcription resulting in a
reduction in the amount of radiolabeled RF RNA after shift
could be due to a decrease in negative- and/or positive-strand
RNA synthesis. For the positive-stranded RNA viruses, it is
understood that viral mRNA is transcribed from a complemen-
tary negative-strand RNA. Nascent viral RNA is located in the
RI RNA, and following RNase digestion, much of the recently
transcribed RNA remains affiliated with double-stranded RF
RNA cores. Consequently, the rate at which label is incorpo-
rated into RF RNAs should be a direct measure of the rate of
single-stranded RNA synthesis from its template (3, 4, 31, 33,
36, 37, 39). In an attempt to definitively distinguish between
the two possible defects in NC3, we calculated the rates of
mRNA synthesis by using the formula developed for SB virus
(3, 39). Rate calculations for SB virus with pulse-labeling
periods from only a few minutes to 2 h have been studied. Only
minor variations in the times required to transcribe a given
mRNA from its equivalent same-sized template have been
noted (3, 39). For MHV, which has template RNAs ranging
from 1.7 to 32 kb (33), the longer radiolabeling times (1 h)
used in these studies would ensure that all of the RIs would be
fully saturated with label, providing a more accurate estimate
of the time required to synthesize a given mRNA from its
template (39). IfmRNA degrades or if negative-stranded RNA
is also radiolabeled during the labeling period, our findings
would probably represent the upper limit on the time required
to transcribe a given mRNA from its particular template (39).
Since our previous results corroborated studies by other
laboratories and indicated that subgenomic negative strands
were functional templates throughout infection (33, 36, 37), we
addressed the question by calculating the rates of mRNA 1, 3,
6, and 7 synthesis from 6 to 7, 7 to 8, and 8 to 9 h p.i., assuming
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FIG. 6. Effect of temperature shift on mRNA and RF RNA synthesis. Corrected net cpm for NC3 (A), NC3-Rev2 (B), and NC3 RF1 versus
RF7 (C) are shown. Symbols for panels A and B: 0, mRNA at 32°C; 0, mRNA at 39.5°C; *, RF RNA at 32°C; [, RF RNA at 39.50C. Symbols
for panel C: *, RF1 at 320C, El, RF1 at 39.5°C; *, RF7 at 32°C; 0, RF7 at 39.5°C.
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TABLE 3. Relative percent molar ratio of full-length and subgenomic-length mRNA and RF RNA after the shift
Relative % molar ratioa (n = 3) of:
Viral Mol wt of RF RNA (320C) RF RNA (39°C) mRNA (32°C) mRNA (39.5°C)RNA species mRNA
NC3 NC3-Rev2 NC3 NC3-Rev2 NC3 NC3-Rev2 NC3 NC3-Rev2
1 -9.79 x 106 8.8 ± 1.2 9.0 ± 0.2 7.3 ± 0.8 5.8 ± 0.2 0.70 ± 0.2 0.8 ± 0.2 1.21 ± 0.6 0.50 ± 0.2
2 3.04 x 106 8.2 ± 1.9 10.9 ± 2.1 6.1 ± 1.6 6.6 ± 0.7 4.6 ± 0.5 4.9 0.8 5.9 ± 0.9 3.3 ± 0.8
3 2.40 x 106 8.3 ± 0.9 10.3 ± 1.7 6.0 ± 0.9 8.0 ± 1.2 6.9 ± 0.8 6.6 ± 0.8 7.0 ± 0.3 5.0 ± 0.8
4 1.15 x 106 8.5 ± 0.6 7.5 ± 1.5 9.9 ± 2.0 7.1 ± 1.1 11.7 ± 0.5 10.7 ±0.5 10.5 ± 1.3 9.8 ± 1.8
5 1.0 X 106 10.3 ± 1.2 9.8 ± 1.0 13.8 ± 2.8 9.6 ± 0.7 13.7 ± 2.4 13.3 ± 1.2 12.5 ± 2.4 13.7 ± 1.2
6 0.81 X 106 19.8 ± 1.5 16.3 ± 0.8 24.5 ± 3.1 20.0 ± 2.2 17.2 ± 1.3 16.7 ± 1.5 16.4 ± 2.3 18.1 ± 2.3
7 0.56 x 106 36.0 ± 6.9 36.2 ± 5.7 33.0 ± 7.8 42.7 ± 1.3 45.4 ± 0.9 46.8 ± 1.7 46.3 ± 4.5 48.8 ± 5.3
a Mean ± standard deviation.
same-sized subgenomic RI template (or, for mRNA 1, RI 1)
(Table 4) (3, 32, 37, 39). Appropriately, the times required to
transcribe mRNA from a corresponding subgenomic-length
template increased with increasing size of the mRNA and at
32°C were roughly equivalent between NC3 and NC3-Rev2.
Although some variability was evident, especially in the times
required to transcribe genomic RNA, this was probably due to
minor amounts of degradation following extraction and from
the packaging and release of genome-length RNAs in progeny
virions. Less time was required to synthesize equivalent-sized
mRNA at 39.5°C than at 32°C for both NC3 and NC3-Rev2,
indicating that positive-strand synthesis was not significantly
inhibited in NC3-infected cultures after the temperature shift.
We also calculated rates of mRNA synthesis, assuming that
only the full-length template was functional and mRNA syn-
thesis occurred by leader-primed transcription (4). The leader-
A











FIG. 7. NC3 mRNA and RF RNA synthesis after an early temper-
ature shift. 17CL1 cells were infected with NC3 at an MOI of 10 for 1
h. At 1.5 and 3.0 h p.i., half of the cultures were shifted to the
restrictive temperature and radiolabeled with 500 ,uCi of [3H]uridine
per ml from 4 to 6 h p.i. The radiolabeled RNAs were separated on
0.8% agarose gels, soaked in Enlightening, and exposed to film for 36
days. (A) NC3 mRNA. Lanes: 1, NC3 mRNA from 3 to 4 h p.i. at 32°C;
2, NC3 mRNA after the shift at 1.5 h to 39.5°C and labeled from 3 to
4 h p.i.; 3 NC3 mRNA from 4 to 5 h p.i. at 32°C; 4, NC3 mRNA after
a shift at 3.0 h to 39.5°C and labeled from 4 to 5 h p.i. (B) NC3 RF
RNA. Lanes: 1, NC3 RF RNA at 3 to 4 h p.i.; 2, NC3 RF RNA after
the shift at 1.5 h to 39.5°C and labeled from 3 to 4 h p.i.; 3, NC3 RF
RNA at 4 to 5 h p.i.; 4, NC3 RF RNA after the shift at 3.0 h to 39.5°C
and labeled from 4 to 5 h p.i.
primed transcription model proposes that only the portion of
the full-length RI equivalent to the size of a given mRNA
contributes to the synthesis of that mRNA. The model also
proposes that the ratio of nascent positive strands on the RI
RNA (or the rate of synthesis of a given mRNA) is dictated by
leader priming from unique intergenic start sites. Conse-
quently, the ratio of the nascent positive strand of each mRNA
on the RI RNA will directly determine the final ratio of each
mRNA transcribed throughout infection (4). The complexity
of a full-length RI transcribing subgenomic mRNA by leader-
primed transcription has required a significant modification of
the standard formula (see Materials and Methods). As with the
previous calculations, the times were comparable between
NC3 and NC3-Rev2 at 32°C, with more time required to
synthesize larger mRNAs (Table 5). Synthesis was also in-
creased at 39.5°C compared with 32°C for NC3 and its
revertants, demonstrating that the defect in NC3 did not affect
the rate of positive-strand RNA synthesis. However, the time
required to synthesize any mRNA from the full-length tem-
plate was drastically reduced compared with that from the
subgenomic-length template, indicating that mRNA synthesis
must be extremely efficient if it is derived only from a full-
length RI.
To investigate the statistical significance of the increased
rates of mRNA synthesis following the shift to 39.5°C with
NC3, we calculated the average rate (in nucleotides per
minute) of RNA transcription at 32 and 39.5°C from mRNAs
1, 3, 6, and 7 at 6 to 7, 7 to 8, and 8 to 9 h p.i., assuming that
a same-sized template was functional (Table 6). No significant
differences (n = 12) were detected in the rate of transcription
between NC3 and NC3-Rev2 at 32°C, assuming that either a
TABLE 4. Putative times required to transcribe mRNA from
subgenomic replicative intermediates at the permissive
and restrictive temperatures
Time (min) for transcription at:
mRNA species Permissive temp Restrictive temp
6-7 h p.i. 7.8 h p.i. 6-7 h p.i 7-8 h p.i.
NC3 mRNA7 1.45 1.92 1.09 1.01
NC3 mRNA6 2.80 2.75 1.93 2.75
NC3 mRNA3 3.32 2.80 1.61 1.53
NC3 mRNA1 27.00 23.70 10.90 17.20
NC3-Rev2 mRNA7 1.38 2.55 1.46 2.05
NC3-Rev2 mRNA6 2.22 2.54 1.90 2.54
NC3-Rev2 mRNA3 3.52 4.93 2.21 3.45
NC3-Rev2 mRNA1 25.00 42.40 13.60 26.90
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TABLE 5. Time required for the synthesis of MHV mRNAs from
a full-length negative-strand RNA template
Time (min) for mRNA synthesis at:
mRNA species Permissive temp Restrictive temp
6-7 h p.i. 7-8 h p.i. 6-7 h p.i. 7-8 h p.i.
NC3 mRNA 7 0.13 0.17 0.07 0.05
NC3 mRNA 6 0.17 0.16 0.09 0.08
NC3 mRNA 3 0.56 0.52 0.29 0.26
NC3 mRNA 1 2.15 1.99 1.11 1.02
NC3-Rev2 mRNA 7 0.10 0.16 0.06 0.10
NC3-Rev2 mRNA 6 0.13 0.21 0.08 0.11
NC3-Rev2 mRNA 3 0.46 0.70 0.25 0.38
NC3-Rev2 mRNA 1 1.76 2.67 1.00 1.48
subgenomic-length (P = 0.93) or full-length (P = 0.81) tem-
plate was preferentially functional. However, a significant
increase in the rate of mRNA synthesis from a subgenomic-
length template was evident after the shift to 39.5°C with NC3
(P < 0.05) but not with NC3-Rev2 (P = 0.57).
Assuming that only a full-length RI was acting as a func-
tional template, significant increases in the rate of transcrip-
tion were evident with both NC3 and NC3-Rev2 after the shift
to 39.5°C (P < 0.001). These data demonstrate that the rate of
NC3 mRNA synthesis after the shift is increased at 39.5°C
compared with 32°C regardless of the template used, and they
strongly suggest that the defect in NC3 limits the increase in RI
RNA numbers at 39.5°C by inhibiting new negative-strand
RNA synthesis.
DISCUSSION
The transcriptional strategy of coronaviruses is complex, and
there is considerable controversy about the role of the full-
length and subgenomic-length negative-strand RNAs in
mRNA synthesis. While biochemical and molecular data have
revealed the structure of the subgenomic mRNA, the hetero-
geneity within the leader-body fusion sites, and the structure of
the subgenomic negative-strand RNA, very little genetic sup-
port for any of the current models for MHV transcription has
been obtained. In this study, we have focused on the comple-
mentation group C mutants since previous studies have sug-
gested that these mutants contain an early defect in RNA
synthesis that probably results in a reduction in the amount of
negative-strand RNA after a shift to the restrictive tempera-
ture (35).
The group C mutants are tightly linked by complementation
and standard genetic recombination mapping techniques, yet
TABLE 6. Predicted MHV RNA polymerase rates at the






Subgenomic NC3 1.34 ± 0.7 1.85 ± 1.30
NC3-Rev2 1.34 ± 1.0 1.48 ± 0.8
Full-length NC3 14.68 ± 1.9 26.38 ± 5.8
NC3-Rev2 15.13 ± 2.7 19.50 ± 5.9
'Mean ± standard deviation.
the group Cl mutants synthesize mRNA and produce infec-
tious virus after the temperature shift whereas under identical
conditions the group C2 mutants are defective in the synthesis
of mRNA and virus. We cannot conclusively rule out the
possibility that the group C2 mutants contain a second muta-
tion in a complementation group which is not represented
within our panel of mutants. Thus, while additional experi-
ments are needed to clearly demonstrate the presence of two
noncomplementable functions within complementation group
C, these findings may not be surprising, because there have
been similar reports with ts mutants of SB HR virus (30). For
example, the complementation group A mutants of SB virus
map to nsp2, which functions in 26S mRNA synthesis, the
regulation of negative-strand RNA synthesis, and proteolytic
processing of the nonstructural proteins (10). These defects
are present in some subgroup SB virus Al mutants but not in
the subgroup A2 mutants (10, 30). Alternatively, some group C
mutants of MHV may possess a mutation in a different gene
which does not complement the group C ts allele.
A variety of data support the hypothesis that the group Cl
mutants contain a defect in the ability to synthesize full-length
as well as subgenomic-length negative-strand RNA. Previous
studies with strand-specific probes indicate a -80% loss in
total levels of negative-strand RNA after a shift to 39.5°C,
relative to controls maintained at 32°C (35). Similarly, total RF
RNA synthesis is reduced by about 83 to 92% after the shift to
39.5°C and the block in RNA synthesis prevents the accumu-
lation of both full-length and subgenomic-length RF RNA
equally. Since the rates of positive-strand synthesis at 39.5°C
are at least equal to the rates of 32°C, regardless of the size of
the template, the most logical conclusion is that the group Cl
allele regulates negative-strand RNA synthesis.
Studies on the effect of cycloheximide on MHV RNA
synthesis indicate that the negative-strand polymerase requires
continuing protein synthesis, perhaps for initiation (32). The
putative MHV negative-strand RNA polymerase continues to
function for 1 to 2 h in the absence of protein synthesis,
however, and is more resistant to cycloheximide than is the SB
negative-strand RNA polymerase, which completely ceases
activity after 30 min (31, 32). Slight increases in total NC3 RF
RNA levels are evident after the temperature shift, suggesting
that the defect in NC3 permits low levels of negative-strand
RNA synthesis until the preexisting negative-strand RNA
polymerase decays. SB virus ts mutants, defective in negative-
strand synthesis, also transcribe some negative-strand RNA for
approximately 1 h after the shift to the restrictive temperature
(31). Alternatively, the slow increase in NC3 RF RNA labeling
after the shift may be due to hotter pools of nucleotide
precursors. We believe that this is unlikely, since labeling
periods were identical and similar increases were not detected
within the revertant virus.
Previous studies indicated that the majority (>98%) of
negative-strand RNA was found in RIs in MHV-infected cells
(32). It has also been shown that at 37°C, MHV negative-
strand RNA synthesis peaks at 6 h p.i. and decreases thereaf-
ter, whereas positive-strand RNA synthesis continues (32).
Negative-strand synthesis peaks slightly later (7 to 9 h p.i.) for
ts mutants at 32°C, with peak RF RNA levels occurring by 9 h
p.i. (35). We were able to detect full-length as well as sub-
genomic-length RF RNAs from 3 to 12 h p.i. at 32°C and at
39.5°C after the temperature shift late in infection (9 h p.i.).
Since subgenomic RF RNA was labeled after the temperature
shift late in infection, when negative-strand synthesis had
terminated, these data indicated that the subgenomic negative
strands were continuously functioning as templates for mRNA
synthesis. This is in agreement with previous data indicating
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that after negative-strand synthesis decreased, radiolabel was
incorporated into RIs at a constant rate, suggesting that the
MHV subgenomic negative-strand RNAs were stable (32).
Similar findings have been reported with bovine coronavirus
and transmissible gastroenteritis virus (11, 37).
Additional support for the idea that subgenomic negative
strands are functional templates for positive-strand synthesis is
demonstrated by temperature shift experiments early in infec-
tion. The decrease in total RF RNA synthesis cannot be
attributed to a decrease in positive-strand synthesis, since
positive-strand RNA polymerase rates significantly increase
after the shift to 39.5°C. In the absence of significant amounts
of new negative-strand RNA, full-length and subgenomic-
length RF RNAs are also labeled at a constant rate at different
times after the shift, indicating that the full-length and sub-
genomic-length RIs are stable and transcriptionally active
throughout infection. If subgenomic negative strands are dead-
end transcriptional intermediates, a reduction in the amount of
radiolabel incorporated at 39.5°C into the subgenomic RFs,
but not full-length RFs, should occur over time in cultures
infected with ts mutants transcribing little new negative-strand
RNA. Since this is not the case, we conclude that subgenomic-
length negative- strands are functional templates for the
synthesis of positive-strand RNA throughout infection, as
proposed by Sethna et al. (36, 37) and Sawicki and Sawicki
(33).
Our results and those of others clearly demonstrate that
subgenomic negative strands are the predominant template for
mRNA synthesis late in infection (33, 36, 37). Consonant with
these findings, the times required for the transcription of
mRNA from a subgenomic template are more in line with the
times required to synthesize SB virus 26S mRNA (-2,600
nucleotides/min) as well as other previously published eukary-
otic RNA polymerase rates of approximately 1,800 nucleoti-
des/min (3, 7, 39, 41). Therefore, it appears that the sub-
genomic negative strands are present in sufficient quantities to
act as templates for the amount of mRNA synthesized during
infection. Not surprisingly, the relative percent molar ratios of
mRNA and RF RNA closely parallel each other throughout
infection, readily explaining the concentrations of each viral
mRNA transcribed during infection. These findings are also in
agreement with results of UV transcriptional mapping studies,
which indicate that the UV target size for mRNA synthesis is
equivalent to the size of the mRNA late in infection (12, 43).
The increased rates of positive-strand synthesis from sub-
genomic negative strands in NC3-infected cells at 39.5°C could
be due to either an increase in polymerase activity at higher
temperatures or an altered ratio of positive-strand polymerase
to negative-strand RNA template. Since the revertant virus
had similar transcription rates at 32°C and 39.5°C, the most
logical interpretation of these data is that increased transcrip-
tion rates in NC3-infected cells may be attributed primarily to
an altered ratio of positive-strand polymerase to negative-
strand template. Under these conditions, the observed -10-
fold reduction in NC3 RF RNA template levels might result in
only a ca. twofold reduction in mRNA levels after the shift.
Similar findings have been reported during SB virus transcrip-
tion (3).
In contrast, if leader-primed transcription from full-length
negative-strand RNA is the only mechanism by which sub-
genomic mRNAs are synthesized, it would have to occur at a
remarkable rate and efficiency. In general, polymerases with
high transcription and replication rates have high processivity;
i.e., they do not dissociate from the template easily (7, 39, 41).
This is inconsistent with findings with MHV which suggest that
nascent positive strands are found associated with and disso-
ciated from RI RNA complexes (5) and that high-frequency
RNA recombination may be mediated by a copy choice
mechanism between transcriptionally active full-length and
subgenomic-length RNA intermediates (2, 9, 14, 21, 24). The
most logical interpretation of these data is that late in infec-
tion, subgenomic negative strands represent the major tem-
plate for the synthesis of subgenomic mRNA (33, 36, 37).
The original model for MHV transcription proposed that all
viral mRNAs were synthesized by a leader-primed transcrip-
tion mechanism from a full-length negative-strand RNA. This
model was heavily based on the observation that only a single
full-length negative-strand RNA and RF RNA were present
within MHV-infected cells (16) and on biochemical structural
analyses of exclusion chromatography- and sucrose gradient
size-purified RI RNAs (4). Although we believe that the
biochemical structure of the highly purified full-length RI
RNA is probably correct, since exclusion chromatography and
gradient centrifugation should have removed the smaller
MHV RI RNAs from the purified genome-length RI RNA (4),
there is no question that subgenomic-length negative-strand
RNA and RF RNAs are present, indicating that the original
model must be modified. Current models for the synthesis of
subgenomic negative-strand RNA include primary transcrip-
tion by looping out or transcription attenuation from the
genome-length template (33) and transcription from preexist-
ing mRNA, which was initially synthesized by leader-primed
transcription (32, 36, 37). Elegant studies, which strongly
support the initial synthesis of subgenomic mRNAs by a
leader-primed transcription model, would suggest that the
newly synthesized subgenomic mRNAs act as a template for
the subsequent transcription of subgenomic negative-strand
RNAs containing antileaders (22, 44). However, in contrast to
our results and those of others, it was suggested that neither
the subgenomic-length negative-strand RNAs nor the mRNAs
act as the template for transcription or replication (13, 22).
These arguments are based on experiments which demon-
strated that infectious defective interfering (DI) RNAs, but not
mRNA, replicated and transcribed subgenomic-length
mRNAs following transfection into MHV-infected cells (13,
22). Unfortunately, no compelling evidence was presented that
demonstrated that the negative-strand RNAs were transcrip-
tionally inactive templates, since highly sensitive methods to
detect RI or RF RNAs were not used in these studies.
Moreover, MHV DI RNAs replicate to the detriment of helper
virus and have extremely high rates of transcription compared
with those of other mRNA and genomic RNAs (23, 26).
Within 6 h of transfection, major amounts of MHV DI RNAs
were synthesized compared with SB virus DI RNAs, which
were detected only after several cycles of virus passage (20). In
contrast, synthesis of MHV full-length and subgenomic-length
positive- and negative-strand RNA, but not DI RNAs, is
clearly under tight regulatory control. Consequently, it should
not be surprising that DI RNAs rapidly amplify while mRNA
transcription is not readily detected under identical treatment
conditions. Also, in the highly sensitive in vitro system de-
scribed by Liao and Lai (22), the ability of chimeric mRNA
constructs to act as a template for negative-strand RNA and
similarly sized mRNA synthesis was not evaluated; only the
potential for a larger chimeric mRNA to act as template for
the synthesis of a smaller subgenomic mRNA encoding the
chloramphenicol acetyltransferase reporter gene was dis-
cussed. Recently, mRNA transfection experiments have clearly
demonstrated that in vitro transcribed mRNAs act as template
for RNA recombination and repair of ts lesions consistent with
the notion that subgenomic RNAs participate in transcription
(14). Moreover, the possibility of a cis-acting subgenomic
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negative-strand RNA polymerase cannot be excluded, nor is it
clear whether transfected indicator mRNAs are compartmen-
talized into the appropriate viral ribonucleoprotein structures
required for transcription. Alternatively, the mRNA transfec-
tion studies may support the notion that subgenomic negative-
strand RNA primarily originates from genome-length template
by the transcription attenuation or the looping out model (33).
Careful examination of the literature demonstrates a wealth
of data supporting both an initial discontinuous transcription
mechanism (4, 5, 13, 17, 22, 26, 27, 28, 34, 38) and the synthesis
of mRNA from subgenomic negative strands containing anti-
leaders (11, 33, 34, 36, 37). Since these mechanisms are not
mutually exclusive but, rather, provide coronaviruses with
considerable regulatory control over gene expression, the most
likely interpretation is either that leader-primed transcription
functions early in infection to initially transcribe mRNA, which
is subsequently used as the template for the synthesis of
subgenomic negative-strand RNAs or that subgenomic nega-
tive strands are synthesized directly from a genome-length
template (33). The mechanism by which the subgenomic
negative-strand RNAs act as template for mRNA synthesis is
unknown. It has been suggested that mRNA replication occurs
from subgenomic negative-strand RNAs in a manner similar to
that of genome replication, since the 5' and 3' ends of these
RNAs are identical (37). Alternative models include a cis-
acting RNA polymerase which functions in the initial synthesis
of subgenomic-length negative-strand RNA directly from
newly transcribed subgenomic mRNA templates or that leader-
primed transcription may also function in the synthesis of mRNA
from subgenomic negative strands containing antileaders.
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